CA2150378A1 - Mammalian muscle nad:arginine adp-ribosyltransferase - Google Patents

Mammalian muscle nad:arginine adp-ribosyltransferase

Info

Publication number
CA2150378A1
CA2150378A1 CA002150378A CA2150378A CA2150378A1 CA 2150378 A1 CA2150378 A1 CA 2150378A1 CA 002150378 A CA002150378 A CA 002150378A CA 2150378 A CA2150378 A CA 2150378A CA 2150378 A1 CA2150378 A1 CA 2150378A1
Authority
CA
Canada
Prior art keywords
ribosyltransferase
nad
arginine adp
mammalian muscle
adp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002150378A
Other languages
French (fr)
Other versions
CA2150378C (en
Inventor
Joel Moss
Ian Okazaki
Anna Zolkiewska
Maria S. Nightingale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
Joel Moss
Ian Okazaki
Anna Zolkiewska
Maria S. Nightingale
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joel Moss, Ian Okazaki, Anna Zolkiewska, Maria S. Nightingale, The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services filed Critical Joel Moss
Publication of CA2150378A1 publication Critical patent/CA2150378A1/en
Application granted granted Critical
Publication of CA2150378C publication Critical patent/CA2150378C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]

Abstract

This invention relates to the identification and molecular characterization of NAD:arginine ADP-ribosyltransferases. Sequences from the rabbit skeletal muscle NAD:arginine ADP-ribosyltransferase and the human NAD:arginine ADP-ribosyltransferase are provided herein.
Methods are disclosed for the isolation and identification of these gene sequences.
CA002150378A 1992-11-30 1993-11-29 Mammalian muscle nad:arginine adp-ribosyltransferase Expired - Fee Related CA2150378C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98569892A 1992-11-30 1992-11-30
US07/985,698 1992-11-30
PCT/US1993/011569 WO1994012668A1 (en) 1992-11-30 1993-11-29 Mammalian muscle nad:arginine adp-ribosyltransferase

Publications (2)

Publication Number Publication Date
CA2150378A1 true CA2150378A1 (en) 1994-06-09
CA2150378C CA2150378C (en) 2007-10-30

Family

ID=25531716

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002150378A Expired - Fee Related CA2150378C (en) 1992-11-30 1993-11-29 Mammalian muscle nad:arginine adp-ribosyltransferase

Country Status (6)

Country Link
US (1) US5834310A (en)
EP (2) EP0673440A4 (en)
JP (1) JP3352691B2 (en)
AU (1) AU688749B2 (en)
CA (1) CA2150378C (en)
WO (1) WO1994012668A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593877A (en) * 1993-03-11 1997-01-14 The Rockefeller University Nucleic acid and recombinant production of vespid venom hyaluronidase
DE19808889A1 (en) * 1998-03-03 1999-09-09 Deutsches Krebsforsch Vectors and viruses for gene therapy
US20050100896A1 (en) * 2000-09-23 2005-05-12 Miller Jeffery L. Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
AU2002367187A1 (en) * 2001-12-27 2003-07-15 Bayer Aktiengesellschaft Regulation of human mono (adp-ribosyl) transferase-like protein
AU2003215257A1 (en) 2002-02-19 2003-09-09 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Modified defensins and their use
AU2003247826B2 (en) * 2002-06-28 2008-04-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
CA2739944A1 (en) * 2008-01-23 2009-07-30 Rigshospitalet Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40
US10917454B1 (en) 2019-08-01 2021-02-09 Rohde & Schwarz Gmbh & Co. Kg System and method for ATC voice quality assurance
CN112772553B (en) * 2020-12-31 2022-12-20 吉林康安兔业有限公司 Method for cultivating cold-resistant rabbits

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (en) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4634665A (en) * 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4948882A (en) * 1983-02-22 1990-08-14 Syngene, Inc. Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
US4792520A (en) * 1984-02-16 1988-12-20 University Of Cincinnati Methods and kits for identifying mutagenic agents and molecular mutations in DNA in mammalian cells
US4675285A (en) * 1984-09-19 1987-06-23 Genetics Institute, Inc. Method for identification and isolation of DNA encoding a desired protein
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
GB2244704B (en) * 1990-05-04 1995-05-17 Consultants Suppliers Limited Substituted benzene compounds

Also Published As

Publication number Publication date
EP0673440A4 (en) 1997-10-01
US5834310A (en) 1998-11-10
AU5869594A (en) 1994-06-22
JPH08503616A (en) 1996-04-23
WO1994012668A1 (en) 1994-06-09
EP1333093A3 (en) 2008-09-10
AU688749B2 (en) 1998-03-19
JP3352691B2 (en) 2002-12-03
EP1333093A2 (en) 2003-08-06
EP0673440A1 (en) 1995-09-27
CA2150378C (en) 2007-10-30

Similar Documents

Publication Publication Date Title
CA2194660A1 (en) Growth differentiation factor-11
EP1435352A3 (en) 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
WO1995033819A3 (en) Cdk4 (cyclin dependent kinase 4) binding proteins
AU8154994A (en) Methods of inhibiting pulmonary hypertensive diseases
AU2930697A (en) Identification of essential survival genes
AU5727296A (en) 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
CA2263713A1 (en) Lyophilization of cultured human cells to preserve rna and dna
HUP9901688A3 (en) Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
CA2150378A1 (en) Mammalian muscle nad:arginine adp-ribosyltransferase
AU1870597A (en) Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
AU6144590A (en) Lactam-containing compositions and methods useful for the hybridization of nucleic acids
AU3408493A (en) Process for the preparation of dialkyl 2,3-pyridinedicarboxylate and derivatives thereof from an alpha,beta-unsaturated oxime and an aminobutenedioate
PL298322A1 (en) Novel 9-fluoro-7-oxo-7h-pyrido/1, 2, 3-de//1,4/-benzoxazine -6-carboxylic acids and their esters, method of obtaining them and therapetic agents containing them
AU1443095A (en) Novel nucleic acid sequences isolated from glial cells
CA2197233A1 (en) Methods of Identifying Compounds Useful for Treating Autoimmune Diseases
AU7047794A (en) Detection of nucleic acid sequences
NZ310561A (en) Immunosuppressant of the aromatic variety based upon the quinoline family
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
AU5551398A (en) The use of polyether-polyurethane for safety clothing
CA2115151A1 (en) Tau/neurofilament protein kinases pk40 and pk36
AU9247698A (en) Method for the identification of essential genes and therapeutic targets
AU6273894A (en) Alkaloid compounds extracted from (cryptolepis sanquinolenta) and uses thereof
AU7362294A (en) Mammalian low molecular weight phospholipase a2 nucleotide and amino acid sequences
AU4884796A (en) Use of n-substituted l-phenylalanine esters for the treatmentof eczema
AU2310097A (en) Identification of stimuli

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed